Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
F-star Therapeutics, Inc. (SBPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
SC 13G
| Beryl Capital Management LLC reports a 0% stake in F-Star Therapeutics, Inc. |
| 05/18/2021 |
SC 13G
| Point72 Asset Management, L.P. reports a 5.7% stake in F-star Therapeutics, Inc. |
| 05/17/2021 |
SC 13G
| Rock Springs Capital Management LP reports a 5.7% stake in F-star Therapeutics, Inc. |
| 05/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2021 |
SC 13G
| Atlas Venture Opportunity Fund I, L.P. reports a 6.6% stake in F-star Therapeutics, Inc. |
| 02/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/30/2020 |
SC 13G
| GLAXOSMITHKLINE PLC reports a 8.9% stake in F-star Therapeutics, Inc. |
| 01/06/2020 |
SC 13G
| Ridgeback Capital Investments L.P. reports a 6.9% stake in Spring Bank Pharmaceuticals, Inc. |
| 10/18/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/11/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2017 |
SC 13G
| Spring Bank Pharmaceuticals, Inc. reports a 6.1% stake in Spring Bank Pharmaceuticals, Inc. |
| 02/10/2017 |
SC 13G
| Iyer Radhakrishnan P. reports a 5.2% stake in Spring Bank Pharmaceuticals, Inc. |
| 12/05/2016 |
SC 13G
| UBS Oncology Impact Fund L.P. reports a 6.4% stake in Spring Bank Pharmaceuticals, Inc. |
|
|